Surgerii Technology

What Surgerii Technology does

Surgerii monetizes its systems through capital equipment sales to tertiary hospitals under multi-year enterprise contracts, supplemented by surgeon training programs, service, and consumables tied to system utilization. The commercial launch began in late 2024, reaching 70+ hospitals and 3,000+ cumulative surgeries within roughly the first twelve months, with anchor customers including top Chinese academic medical centers such as Ruijin, Peking Union Medical College, and Shandong Provincial Hospital. Geographic expansion is underway through an August 2025 EU CE Mark under MDR, including pediatric clearance, and a strategic training partnership with IRCAD in France to support European commercial entry, with capital supplied by a December 2025 $100 million Series D round.

Name

Surgerii Technology

Legal name

Beijing Surgerii Robotics Company Limited

Website

https://surgerii.com

Company type

Private

Founded year

2017

Operating status

Operating

Headcount range

501–1,000 employees

Short description

Beijing-based Surgerii Technology develops single-port laparoscopic surgical robots using proprietary Ni-Ti snake-arm technology. Its SHURUI systems serve tertiary hospitals across urology, gynecology, general surgery, and thoracic surgery, with commercial expansion across China and Europe.

Ownership category

akta.pro rank

Product category

Surgical Robotics (Minimally Invasive Surgical Robots)

NAICS

Surgical and Medical Instrument Manufacturing (339112), Electromedical and Electrotherapeutic Apparatus Manufacturing (334510)

SIC

Surgical & Medical Instruments & Apparatus (3841), Electromedical & Electrotherapeutic Apparatus (3845)

akta.pro primary industry

Surgical Robotics & Computer-Assisted Surgery Platforms (HLAHADAF)

akta.pro secondary industries

Open & Minimally Invasive Surgical Instruments (Handheld, Laparoscopic, MIS) (HLAHADAA), Endourology & Minimally Invasive Urologic Surgery (HLAKAOAF), Minimally Invasive Gynecologic Surgery (Laparoscopy/Hysteroscopy) (HLAKAJAF)

Keywords

• Surgical robotics
• Minimally invasive surgery
• Single-port endoscopic robot
• Laparoscopic surgical systems
• Medical robotics

Headquarters

HQ city

Haidian

HQ country

China

HQ region

Asia

Offices5 records

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Technology or R&D, Supply Chain, Marketing or Sales, Personnel, Infrastructure

Revenue model

1. Surgical Robot Hardware Sales: Sale of SHURUI single-port endoscopic surgical system (SR-ENS-600) and related surgical instruments to hospitals.
2. Training and Services: European training center established with IRCAD provides training services. Service offerings include clinical support and system maintenance.

Pricing tiers

Go-to-market motion1 record

Distribution channels3 records

Marketing channels5 records

Core offering

Surgerii Technology designs, manufactures, and commercializes single-port endoscopic surgical robotic systems (SHURUI SR-ENS-600 and SR-ENS-660) featuring proprietary snake-like arm instruments for minimally invasive laparoscopic procedures across urology, gynecology, general surgery, and thoracic surgery. The company also offers training programs, clinical support services, and advanced energy surgical instruments (S-Energy).

Product overview

Surgerii Technology offers a portfolio of single-port laparoscopic surgical robotic systems and accessories. The core product is the SHURUI Single-port Endoscopic Surgical System (SR-ENS-600/SR-ENS-660), which uses the world's first snake-like arm technology based on proprietary deformation-driven control for continuous mechanisms. The portfolio includes the new-generation SR-ENS-660, the S+suite ultra-minimally invasive surgical innovation platform enabling single-multi-port integration, and the S-Energy high-energy instrument matrix. These products work together to provide comprehensive surgical robot solutions covering urology, gynecology, general surgery, and thoracic procedures, with training and support services including the European IRCAD training center partnership.

Differentiator

Problem solved

Functional benefit

Brands

• SHURUI Single-port Surgical Robot (SR-ENS-600): The world's first commercially available single-port surgical robot with snake-like instruments, used for urology, gynecology, general surgery, and thoracic surgery procedures.
• SR-ENS-660
• S+ Single Multi-port Integration System
• S+suite
• S-Energy
• S+ Single Multi-port Integration System

Products and services

• SHURUI Single-port Endoscopic Surgical System (SR-ENS-600) World's first commercially available single-port surgical robot with snake-like instruments using proprietary deformation-driven control technology. Features 3 snake-arm instruments and 1 endoscope through a 2.5cm cannula. Approved for urology, gynecology, general surgery, and thoracic laparoscopic procedures in both adult and pediatric patients, for hospital surgical departments.
• SR-ENS-660 Next-Generation Full-Domain Single-Port Surgical Robot Second-generation full-domain single-port surgical robot launched at CMEF 2025 with enhanced capabilities and broader application range compared to the SR-ENS-600. For hospital surgical departments seeking next-generation minimally invasive surgical robotics.
• S+suite Ultra-Minimally Invasive Surgical Innovation Platform Ultra-minimally invasive surgical innovation platform launched at CMEF 2025, enabling single-port and multi-port integrated surgical capabilities to support the transition to the single-port era. For hospital surgical departments.
• S+ Single-Multi-Hybrid Port Integration System World's first integrated system enabling three surgical modes (single-port, multi-port, and hybrid-port) on a single platform, launched at CUA2025 with Variable Aperture Technology. For hospital surgical departments requiring multi-mode surgical capability.
• S-Energy High-Energy Instrument Matrix Advanced energy instrument platform for various surgical procedures, providing enhanced surgical capabilities to complement the SHURUI robotic systems. For hospital surgical departments.
• Service & Training Programs Training programs and clinical support services including European training center partnership with IRCAD in France. The Shu Guang Action nationwide training program establishes single-port surgical robot training centers at partner hospitals across China.

Quantifiable outcome

• Over 3,000 surgeries completed since commercial launch in late 2024
• +3 more outcomes

Named customers8 records

Segments3 records

Ideal customer profiles3 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature4 records

Partnerships

Two partnerships are on record, tiered core.

• IRCADcoreStrategic or Co-development Partner · 1 January 2025European training center partnership established in 2025; long-term strategic cooperation agreement signed July 2025 at SRS World Robot Surgery Conference in Strasbourg
• Shanghai Jiao Tong UniversitycoreStrategic or Co-development PartnerCore technology developed by Professor Xu Kai at Shanghai Jiao Tong University; company founded under university's technology transfer policy

Scale indicators7 records

Recent moves12 records

Expansion highlights7 records

Direct peers

• Medicaroid: Japanese-J&J joint venture developing the Hinotori surgical robot system, a multi-port laparoscopic robot for urology, gastroenterology, gynecology, and thoracic surgery. Competes with Surgerii in Asia-Pacific and potentially in Europe.
• Intuitive Surgical: Global leader in surgical robotics with the da Vinci platform and the da Vinci SP single-port system — the most direct competitor to Surgerii's SHURUI system, particularly in Europe following Surgerii's CE mark. Competes head-to-head in urology, gynecology, and general surgery laparoscopic procedures.
• Medtronic: Medtronic's Hugo RAS system is a multi-port laparoscopic surgical robot competing in urology and gynecology. Medtronic is simultaneously a strategic B+ investor and commercial partner of Surgerii (October 2021), creating a partner-competitor dynamic in surgical robotics.
• CMR Surgical: UK-based developer of the Versius surgical robotic system, a modular multi-port laparoscopic robot targeting urology, gynecology, and general surgery. Competes with Surgerii for European hospital sales following Surgerii's CE mark approval.
• Edge Medical Robotics: Chinese developer of the TouMai laparoscopic surgical robot, a direct domestic competitor to Surgerii's SHURUI system with overlapping NMPA approvals in urology, gynecology, and general/thoracic surgery. Competes for the same Chinese hospital procurement budgets.
• MicroPort MedBot (Shanghai MicroPort MedicalBot): Chinese surgical robotics subsidiary of MicroPort developing the Toumai-series and SkyWalker laparoscopic/orthopedic surgical robots. One of the most capitalized Chinese competitors with overlapping laparoscopic surgery indications.

Emerging players

• Distalmotion: Swiss developer of the Dexter surgical robot, designed for both single-port and multi-port laparoscopic procedures. A direct single-port competitor to Surgerii in Europe with CE mark and an overlapping indication profile.
• Tinavi Medical Technologies: Chinese orthopedic and neurosurgical robot developer; while its core focus is spine/ortho, it represents a fellow Chinese surgical robotics company listed on the STAR Market with overlapping capital-markets and regulatory pathways relevant to Surgerii's long-term trajectory.
• Asensus Surgical: US-listed developer of the Senhance surgical robot system with a focus on digital laparoscopy. A smaller, capital-constrained competitor pursuing laparoscopic indications similar to Surgerii's, though with a different technology approach (shaft-based instruments).

Regional players

• Shiyu Robot (Wedo Bio-Medical): Chinese surgical robot developer with laparoscopic systems in clinical development; another emerging Chinese peer targeting overlapping urology/gynecology/general surgery indications. Comparable as a domestic competitor for Chinese hospital procurement.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks6 records

Key highlights7 records

Customer concentration

• LinkedInlinkedin.com/company/surgerii-robotics

Compliance4 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles6 records

Funding overview

Funding rounds5 records

Investors16 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Surgerii Technology